SLXNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SLXNW
Silexion Therapeutics Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.15+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $105.17K
- P/E (TTM)
- 0.0
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| May 29, 2026 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Aug 12, 2025(first seen in filings) | 1-for-135 reverse | Earlier per-share figures multiplied by 135 |
| Jul 29, 2025 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |